Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments

National10 articles from 8 sources across the spectrum· Updated 1030d ago

7 across the spectrum · tap a section to jump

How each side is putting it

Left

1 viewpoint

BloombergLean Left· 1030d ago

Roche Buys Obesity Drug Developer Carmot for Up to $3.1 Billion

BloombergLean Left· 1030d ago

Obesity Drug Investors Get Windfall After Roche Buys Into Frenzy

4 viewpoints

ForbesCenter· 1030d ago

Roche Will Buy Obesity And Diabetes Drugmaker Carmot Therapeutics In $2.7 Billion Deal

Roche to Buy Carmot Therapeutics for Up to $3.1 Billion in Bet on Obesity Treatments

Ran by 3 outlets· NBC Chicago, NBC10 Philadelphia, +1 more

NBC ChicagoLean Left· 1030d ago

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

NBC10 PhiladelphiaLean Left· 1030d ago

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Roche enters obesity market with Carmot takeover but drugs may not be available until 2030

Geneng NewsCenter· 1030d ago

Roche to Acquire Carmot Therapeutics for Up to $3.1B

2 viewpoints

FortuneLean Right· 1030d ago

Roche pushes to catch up to Novo Nordisk’s Wegovy with $3.1bn deal for obesity drugmaker Carmot

Roche Stock Rises On $3.1 Billion Deal For Obesity Drugmaker